EP3710439
KRAS G12C HEMLAR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.11.2018EP published:
15.2.2023EP application number:
18879484.6
EP translation filed:
17.4.2023Grant published:
15.5.2023EPO information:
European Patent Register
Max expiry date:
13.11.2038Expiry date:
13.11.2026Next due date:
30.11.2026
Title in English:
KRAS G12C INHIBITORSLanguage of the patent:
English
Timeline
Today
14.11.2018EP application
15.2.2023EP Publication
17.4.2023Translation submitted
15.5.2023Registration published
13.11.2026Expires
Owner
Name:
Mirati Therapeutics, Inc.Address:
Route 206 and Province Line Road, Princeton, New Jersey 08543, US
Name:
Array Biopharma Inc.Address:
3200 Walnut Street, Boulder, CO 80301, US
Inventor
Name:
BLAKE, James, F.Address:
Boulder, CO 80301, US
Name:
BURGESS, Laurence, E.Address:
Boulder, CO 80301, US
Name:
CHICARELLI, Mark, JosephAddress:
Boulder, CO 80301, US
Name:
CHRISTENSEN, James, GailAddress:
San Diego, CA 92121, US
Name:
COOK, AdamAddress:
Boulder, CO 80301, US
Name:
FELL, Jay, BradfordAddress:
Boulder, CO 80301, US
Name:
FISCHER, John, P.Address:
Boulder, CO 80301, US
Name:
MARX, Matthew, ArnoldAddress:
San Diego, CA 92121, US
Name:
MEJIA, Macedonio, J.Address:
Boulder, CO 80301, US
Name:
SAVECHENKOV, PavelAddress:
Boulder, CO 80301, US
Name:
VIGERS, Guy, P.A.Address:
Boulder, CO 80301, US
Name:
SMITH, Christopher, RonaldAddress:
San Diego, CA 92130, US
Name:
RODRIGUEZ, Martha, E.Address:
Boulder, CO 80301, US
Name:
TANG, Tony PisalAddress:
Boulder, CO 80301, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201762586775 PDate:
15.11.2017Country:
US
Supplementary protection
SPC number:
SPC472
Classification
Categories:
C07D 401/06, C07D 401/14
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 6.11.2023
Expires: 13.11.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 8.10.2024
Expires: 13.11.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 11.11.2025
Expires: 13.11.2026
Payer: Árnason Faktor ehf.